Lexeo Therapeutics, Inc. Common StockLXEONASDAQ
Loading
Interest Expense Over TimeExpanding
Percentile Rank60
3Y CAGR+15.2%
5Y CAGR-1.1%
Year-over-Year Change
Interest expense on outstanding debt
3Y CAGR
+15.2%/yr
Annual compound
5Y CAGR
-1.1%/yr
Recent acceleration
Percentile
P60
Within normal range
vs 5Y Ago
0.9x
Contraction
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $139000.00 | +21.9% |
| 2024 | $114000.00 | -44.4% |
| 2023 | $205000.00 | +125.3% |
| 2022 | $91000.00 | - |
| 2021 | $0.00 | -100.0% |
| 2020 | $147150.00 | - |